Sequential Treatment of Sorafenib –Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis
ConclusionThis study provides additional proof of the superiority of the S –R treatment over the S–P treatment approach in advanced HCC patients from a real-life setting.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Italy Health | Liver Cancer | Study